A study out of China found most patients biopsied for prostate lesions did not have clinically significant cancer, calling the clinical ranking systems into question.

Gregg Stone, MD, explains the details of the late-breaking RELIEVE-HF trial at ACC.24, where an inter-atrial shunt improved symptoms in HFrEF, but not in HFpEF patients.

In a study, the most accurate model combined deep-learning with a radionomics approach.

Howard C. Herrmann, MD, principal investigator of the SMART trial, discussed his team's research on self-expanding vs. balloon-expandable TAVR valves in patients with small annuli. 

Seeking ways to protect the brain, the researchers found a gene called KNNJ2 that aids in muscle contraction and relaxation.

The authors recommend tweaking pelvic ultrasound with new maneuvers that produce clearer images.

ACC.24 in Atlanta began Saturday, April 6, with a series of late-breaking clinical trials exploring brand new treatment strategies. 

HIV carries a fourfold increase in risk of sudden cardiac death, even in asymptomatic patients.